Reynders McVeigh Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.6M Sell
76,014
-181
-0.2% -$42.2K 0.94% 35
2025
Q4
$15.8M Sell
76,195
-2,402
-3% -$475K 0.74% 40
2025
Q3
$14.6M Buy
78,597
+1,771
+2% +$303K 0.68% 43
2025
Q2
$11.7M Sell
76,826
-4,589
-6% -$705K 0.59% 42
2025
Q1
$13.5M Sell
81,415
-4,105
-5% -$642K 0.75% 38
2024
Q4
$12.4M Sell
85,520
-2,454
-3% -$380K 0.65% 40
2024
Q3
$14.3M Sell
87,974
-2,587
-3% -$412K 0.76% 38
2024
Q2
$13.2M Sell
90,561
-3,629
-4% -$540K 0.75% 38
2024
Q1
$14.9M Sell
94,190
-1,837
-2% -$292K 0.86% 38
2023
Q4
$15.1M Sell
96,027
-3,309
-3% -$507K 0.95% 35
2023
Q3
$15.5M Sell
99,336
-2,913
-3% -$481K 1.06% 32
2023
Q2
$16.9M Buy
102,249
+3,701
+4% +$597K 1.11% 31
2023
Q1
$15.3M Sell
98,548
-2,827
-3% -$456K 1.05% 34
2022
Q4
$17.9M Sell
101,375
-6,749
-6% -$1.17M 1.32% 31
2022
Q3
$17.7M Sell
108,124
-3,889
-3% -$658K 1.37% 29
2022
Q2
$19.9M Sell
112,013
-2,924
-3% -$521K 1.49% 26
2022
Q1
$20.4M Sell
114,937
-301
-0.3% -$51.2K 1.24% 30
2021
Q4
$19.7M Sell
115,238
-2,452
-2% -$401K 1.12% 31
2021
Q3
$19M Sell
117,690
-1,424
-1% -$243K 1.16% 31
2021
Q2
$19.6M Sell
119,114
-1,853
-2% -$307K 1.2% 29
2021
Q1
$19.9M Sell
120,967
-1,856
-2% -$300K 1.33% 28
2020
Q4
$19.3M Buy
122,823
+1,478
+1% +$218K 1.32% 29
2020
Q3
$18.1M Sell
121,345
-1,369
-1% -$203K 1.39% 26
2020
Q2
$17.3M Buy
122,714
+3,072
+3% +$448K 1.51% 26
2020
Q1
$15.7M Sell
119,642
-13,979
-10% -$1.98M 1.79% 22
2019
Q4
$19.5M Sell
133,621
-27,557
-17% -$3.74M 1.88% 20
2019
Q3
$20.9M Sell
161,178
-19,305
-11% -$2.54M 2.23% 17
2019
Q2
$25.1M Sell
180,483
-19,217
-10% -$2.66M 2.7% 13
2019
Q1
$27.9M Sell
199,700
-22,091
-10% -$2.96M 3.09% 6
2018
Q4
$28.6M Sell
221,791
-2,465
-1% -$344K 3.8% 3
2018
Q3
$31M Buy
224,256
+2,461
+1% +$327K 3.64% 3
2018
Q2
$26.9M Buy
221,795
+568
+0.3% +$70.9K 3.43% 3
2018
Q1
$28.4M Buy
221,227
+16,338
+8% +$2.21M 3.59% 3
2017
Q4
$28.6M Sell
204,889
-13,617
-6% -$1.9M 3.75% 4
2017
Q3
$28.4M Buy
218,506
+3,785
+2% +$502K 3.7% 5
2017
Q2
$28.4M Sell
214,721
-1,290
-0.6% -$165K 3.8% 3
2017
Q1
$26.9M Sell
216,011
-8,496
-4% -$1.01M 3.7% 3
2016
Q4
$25.9M Buy
224,507
+6,690
+3% +$773K 3.67% 4
2016
Q3
$25.7M Sell
217,817
-9,677
-4% -$1.17M 3.75% 4
2016
Q2
$27.6M Buy
227,494
+4,509
+2% +$512K 4.01% 3
2016
Q1
$24.1M Buy
222,985
+20,401
+10% +$2.11M 3.57% 3
2015
Q4
$20.8M Buy
202,584
+7,165
+4% +$721K 3.41% 6
2015
Q3
$18.2M Sell
195,419
-8,885
-4% -$859K 3.18% 8
2015
Q2
$19.9M Buy
204,304
+5,875
+3% +$588K 3.25% 6
2015
Q1
$20M Buy
198,429
+13,856
+8% +$1.41M 3.43% 6
2014
Q4
$19.3M Buy
184,573
+3,209
+2% +$338K 3.39% 5
2014
Q3
$19.3M Buy
181,364
+34,378
+23% +$3.57M 3.67% 4
2014
Q2
$15.4M Sell
146,986
-2,952
-2% -$298K 3.5% 4
2014
Q1
$14.7M Buy
149,938
+4,997
+3% +$463K 3.49% 4
2013
Q4
$13.3M Buy
144,941
+1,665
+1% +$153K 3.28% 6
2013
Q3
$12.4M Buy
143,276
+15
+0% +$1.35K 3.45% 5
2013
Q2
$12.3M Buy
+143,261
New +$12.2M 3.65% 4

Other funds holding JNJ

Reynders McVeigh Capital Management's JNJ Position: Q1 2026 in Review

Reynders McVeigh Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.24% in Q1 2026, selling an estimated $42.2K and leaving 76,014 shares worth $18.6M. The position accounts for 0.94% of the portfolio, ranked #35.

Reynders McVeigh Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $31M in Q3 2018. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Reynders McVeigh Capital Management held 76,014 shares of Johnson & Johnson worth $18.6M as of Q1 2026.
  • Reynders McVeigh Capital Management sold 181 Johnson & Johnson shares in Q1 2026, an estimated $42.2K.
  • Johnson & Johnson made up 0.94% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #35 holding.
  • Reynders McVeigh Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Reynders McVeigh Capital Management's Johnson & Johnson position peaked at $31M in Q3 2018.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.